Patent · US Active

Monoclonal antibodies against CD32B

US8802089B2 · kind B2 · utility

3Cited by
0References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 19, 2008
Grant dateAug 12, 2014
Priority date
Expiry dateMar 26, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Isolated monoclonal antibodies which bind to human CD32b and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.